A Study to Assess the Safety of Budesonide/Glycopyrronium/Formoterol Fumarate With a Next-Generation Propellant in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Clinical trial NCT05573464 · COMPLETED
Trial details
- NCT number
- NCT05573464
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-27
- Primary completion
- 2024-03-26
- Enrollment
- 559
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.